<p>Dr. Greg Riely from Memorial Sloan-Kettering notes how he feels molecular marker results for patients with earlier stage lung cancer can potentially be valuable.</p>

Dr. Greg Riely from Memorial Sloan-Kettering notes how he feels molecular marker results for patients with earlier stage lung cancer can potentially be valuable.

Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

Share Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients

Sign up to save your podcasts

Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients

Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients

More shows like GRACEcast Radiation Oncology Video

GRACEcast Head and Neck Cancer Audio

GRACEcast Lung Cancer Video

GRACEcast Radiation Oncology Audio

GRACEcast Pancreatic Cancer Audio

GRACEcast Pancreatic Cancer Video

GRACEcast Cancer 101 Audio

GRACEcast Bladder Cancer Video

GRACEcast Head and Neck Cancer Video NEW

GRACEcast Cancer 101 Video